> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Healthcare Supply Chain Fraud Up: Deloitte
- URL: https://www.fdaweb.com/healthcare-supply-chain-fraud-up-deloitte/
- Published: 2016-04-06T12:00:00.000Z
- Updated: 2026-09-14T20:53:12.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5135292

> Life sciences and healthcare respondents to a Deloitte [poll](http://www.prnewswire.com/news-releases/supply-chain-fraud-levels-unchanged-for-third-consecutive-year-300245152.html?ref=fdaweb.com) say that supply chain fraud increased to 35% of companies in 2016 from 31% in 2014\. Overall, poll respondents from many sectors reported that for the third consecutive year, the level of supply chain fraud remained at about 30%.  
>  
> “From a life sciences and healthcare perspective,” says Deloitte Advisory principal **Mark Pearson**, “regulatory and legislative pressure is expected to heighten around pricing and transparency for plans, providers, and pharma and device makers. It’s a good time to verify that your supply chain is not hiding any unsavory vendors or other fraud, waste and abuse that could cause reputational harm and costly remediation later.”